Drug Profile
NGD 4715
Alternative Names: NGD-4715Latest Information Update: 10 Jan 2008
Price :
$50
*
At a glance
- Originator Neurogen Corporation
- Class Obesity therapies
- Mechanism of Action MCHR1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity